Company Profile

Biomed Simulation Inc
Profile last edited on: 12/11/17      CAGE: 7CVR7      UEI: MUJCBZ3M8L57

Business Identifier: Patient simulators for training operators of life support systems used during thoracic surgery
Year Founded
2011
First Award
2016
Latest Award
2016
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

9939 Via Pasar
San Diego, CA 92126
   (614) 378-0895
   N/A
   www.biomedsimulation.com
Location: Single
Congr. District: 52
County: San Diego

Public Profile

Biomed Simulation is organized around providing training of perfusionists and critical care specialists. As we interact with satisified users we become aware of greater challenges in the training of these specialists. BioMed Simulation’s (BMS) mission is to improve clinician performance through patient-free simulation. Standard of Care Improvement through training and increased proficiency of Perfusionists working in acute clinical care and Operating Room environments represents a significant cost and liability risk reduction for Health Services Providers. The firm's current products include simulation modules for the operation of the Heart Lung Machine – Cardiopulmonary Bypass (CPB) and the Extra Corporeal Membrane Oxygenation (ECMO) machine used in long-term cardiopulmonary support. BMS’ platform roadmap includes other simulators, data analytics interfaces and guideline-based test patient scenarios to continually improve clinician performance and address Healthcare providers conce

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2016 1 NSF $225,000
Project Title: Advancing Simulations with Clinical Scenarios to Enhance Biomedical Training

Key People / Management

  Richard Tallman Jr

  Richard Tallman Sr -- Chief Financial Officer

Company News

There are no news available.